Archived News
2018
September 24, 2018
Court Denies Motion for Summary Judgement In ACLA's PAMA Lawsuit
September 20, 2018
Office of Inspector General Posts Study of CLFS Payments in 2017
September 11, 2018
Curbing Drug Addiction and the Opioid Crisis, NILA White Paper, Press Release
September 7, 2018
PAMA Laboratory Fee Schedule Cuts were Determined Using an Illegal Methodology Says NILA
August 7, 2018
36 Societies Forward Letter Asking Congress To Fix PAMA
August 7, 2018
NILA’s Key Informant Report About Impact of PAMA Cited in Forbes Op-Ed
July 13, 2018
CMS Releases Proposed Changes to the Physician Fee Schedule and Quality Payment Program
July 5, 2018
Laboratory Date of Service Exception
June 28, 2018
NILA Announces 2019 Lab Leaders Forum and Mid-Winter Meeting
May 2, 2018
NILA Report Reveals PAMA’s Adverse Impact on Community, Regional Labs, and Patient Access
April 4, 2018
CMS's Annual Laboratory Public Meeting to be held June 25, 2018, in Baltimore, Maryland
March 23, 2018
CMS Files Cross-Motion for Summary Judgment in PAMA Lawsuit
March 15, 2018
AAB and NILA Respond to RFI Issued by the House Ways and Means Committee Regarding the Opioid Crisis
March 9, 2018
NILA submits comments in response to CMS’ RFI regarding CLIA revisions
March 9, 2018
NILA and 12 Other Lab Groups Forward Letter to CMS Opposing Medicaid Fee Schedule Cuts
March 5, 2018
NILA Signs Addiction Policy Forum Letter
February 21, 2018
AAB/NILA Files Amicus Brief in PAMA Lawsuit
January 4, 2018
2018 Travel Allowance Rate Announced by CMS
January 2, 2018
Congressman Krishnamoorthi (D-IL) Asks CMS to Delay and Fix PAMA Regulations
2017
December 27, 2017
Seven Senate Finance Committee Members Express Concerns About PAMA’s CLFS Cuts for 2018
December 11, 2017
ACLA Files Lawsuit Challenging PAMA Rate Setting Method
November 18, 2017
Final 2018 CLFS Payment Rates Flawed
November 6, 2017
Eight Senators Sign Letter to CMS Secretary Verma Regarding PAMA
October 23, 2017
NILA/AAB Submit Comments on the 2018 Medicare Part B CLFS Proposed Rates
October 6, 2017
22 Organizations Sign Letter to CMS Administrator Seema Verma Urging Suspension of Proposed PAMA Cuts
September 22, 2017
NILA Issues Press Release on Proposed 2018 Medicare CLFS Rates
September 12, 2017
NILA Submits Comments Calling for Changes to PAMA Regulations
August 11, 2017
NILA Comments – Advisory Panel Meeting on Clinical Diagnostic Laboratory Tests
July 21, 2017
CMS Issues Agenda, Code List for July 31 CLFS Public Meeting
July 17, 2017
CMS Requests Feedback from Labs as Part of Physician Fee Schedule Rule
March 30, 2017
Deadline for Reporting PAMA Private Payor Data Extended to May 30, 2017
March 24, 2017
NILA Leads Lab Groups in Calling for Delay and Fix of PAMA
February 27, 2017
New Professional and General Liability Insurance
January 13, 2017
FDA Releases Discussion Paper on Oversight of LDTs
January 10, 2017
CMS Releases Guidance for Submitting Private Payor Data as Required by PAMA
2016
December 15, 2016
NILA Press Release: NILA Applauds House Freedom Caucus Recommendation on Immediate Repeal of Medicare Lab Payment Reform Rule
November 23, 2016
Final Determinations for Repricing Definitive Drug Tests
November 23, 2016
FDA Drops Guidances for LDTS
November 9, 2016
NILA Press Release: Eighty-Eight Members of Congress Sign Bipartisan Letter to HHS Requesting Delay of PAMA
November 7, 2016
Final Bipartisan Sign-On Letter Regarding PAMA Implementation
October 5, 2016
OIG Releases Reports on Medicare Payments for Lab Tests in 2015; Update on CMS’s Progress on Changing How Medicare Pays for Lab Tests
September 12, 2016
NILA Comments on Hospital Outpatient Prospective Payment System (HOPPS)
August 24, 2016
CMS Releases HCPCS Codes to be Reported Under PAMA
August 18, 2016
PAMA Advisory Panel to Meet September 12, 2016
August 17, 2016
FDA Releases Guidance: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus
August 9, 2016
NILA Comments to Support Reconsideration for Final Payment Determinations for Toxicology Codes G0840, G0481, G0482, G0483
August 4, 2016
Medicare Advisory Panel Votes in Favor of NILA's Reconsideration Requests for Toxicology Codes G0480, G0481, G0482, G0483
July 7, 2016
FDA Releases Draft Guidances for Next Generation Sequencing-based Tests
July 6, 2016
HHS announces new actions to combat opioid epidemic
June 30, 2016
NILA Requests CMS to Allow Reconsideration of Tier 1 Codes (G0480)
June 23, 2016
Final PAMA Regulations Published in Federal Register
June 18, 2016
NILA Comments on PAMA Regulations
June 17, 2016
Final PAMA Regulations Released
June 3, 2016
Announcement of the Advisory Panel on Clinical Diagnostic Laboratory Tests Meeting on July 18, 2016
April 14, 2016
NILA Requests Meeting With CMS to Discuss PAMA Regulations
March 28, 2016
Authorization of Emergency Use: In Vitro Diagnostic Device for Diagnosis of Zika Virus Infection
March 17, 2016
May 2, 2016, Workshop on LC/MS-Based Devices
March 3, 2016
Emergency Use of In Vitro Diagnostic Tests for Detection of Zika Virus and/or Diagnosis of Zika Virus
February 1, 2016
AAB's Resource Center for Zika Virus
January 18, 2016
NILA Files Reconsideration Request for CMS’s Drug Coding/Payment Policy
January 7, 2016
Senators Hatch (R-UT) and Wyden (D-OR) Urge CMS to Delay PAMA Reporting System
2015
December 17, 2015
44 U.S. Representatives Sign Letter Regarding CMS’s Proposed PAMA Regulations
December 15, 2015
19 Senators Sign Letter Regarding CMS’s Proposed PAMA Regulations
December 7, 2015
NILA Comments on LCD “MolDX: Biomarkers in Cardiovascular Risk Assessment”
November 24, 2015
NILA Comments on CLFS Proposed Payment System (PAMA Regs)
November 24, 2015
New York Bill Vetoed Requiring NY Personnel Laws to be Applied Nationwide
November 24, 2015
11/10/15 MLN Connects National Provider Call on Clinical Diagnostic Lab Test Payment System Proposed Rule (Transcript)
November 23, 2015
NILA Comments on New CMS Payments for Drug Tests
November 18, 2015
CMS Issues Final Coding / Pricing For Drug Test Codes in CY 2016
November 17, 2015
The Public Health Evidence for FDA Oversight of Laboratory Developed Tests: 20 Case Studies
October 26, 2015
NILA Comments On 2016 Clinical Laboratory Fee Schedule (CLFS) Coding and Pricing Determination For Toxicology Testing.
October 26, 2015
NILA and 7 Other Health Care Organizations Forward Letter To Senate and House Regarding CLIA Modernization and Oversight of LDTs
October 8, 2015
CMS Announces PAMA Advisory Panel Meeting on October 19, 2015
September 29, 2015
NILA Press Release on Proposed PAMA Regulations
September 28, 2015
California Assembly Bill No. 940
September 25, 2015
CY 2016 Clinical Laboratory Fee Schedule Determinations
September 25, 2015
Proposed PAMA Regulations Released
September 10, 2015
New Medicare Policy for CV Risk Assessment Panels
August 28, 2015
Laboratory-developed tests are not the practices of medicine (article via MLO)
August 7, 2015
CMS Announces PAMA Advisory Panel on Clinical Lab Tests
June 17, 2015
CMS Public Meeting on CY 2015 Updates to the Part B Clinical Laboratory Fee Schedule (CFLS)
June 1, 2015
CCLA Lawsuit Regarding Local Coverage Determinations Dismissed (via Pathology Blawg)
May 22, 2015
Palmetto GBA Policy on Next Generation Sequencing (via Palmetto GBA)
February 23, 2015
AAB and NILA Release Comments on HELP Committee Report
February 4, 2015
AAB and NILA Release Comments on FDA's Draft Guidances on LDTs
2014
November 3, 2014
Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems
November 3, 2014
CMS Publishes Physician Fee Schedule Final Rule
September 8, 2014
NILA Comments on 2015 Medicare Physician Fee Schedule Proposed Rule
July 11, 2014
Summary of Calendar Year 2015 Physician Fee Schedule (PFS) Proposed Rule
July 11, 2014
OIG Report on Laboratory Billing Provides More Questions Than Answers
June 25, 2014
Special Fraud Alert: Laboratory Payments to Referring Physicians
June 6, 2014
Amendments (Act No. 122) to Pennsylvania's Clinical Laboratory Act May Cause Problems for Pennsylvania Labs